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Abstract
Background: Acute respiratory disorders may lead to sustained alveolar hypoxia with hypercapnia resulting in
impaired pulmonary gas exchange. Hypoxic pulmonary vasoconstriction (HPV) optimizes gas exchange during local
acute (0-30 min), as well as sustained (> 30 min) hypoxia by matching blood perfusion to alveolar ventilation.
Hypercapnia with acidosis improves pulmonary gas exchange in repetitive conditions of acute hypoxia by
potentiating HPV and preventing pulmonary endothelial dysfunction. This study investigated, if the beneficial
effects of hypercapnia with acidosis are preserved during sustained hypoxia as it occurs, e.g in permissive
hypercapnic ventilation in intensive care units. Furthermore, the effects of NO synthase inhibitors under such
conditions were examined.
Method: We employed isolated perfused and ventilated rabbit lungs to determine the influence of hypercapnia
with or without acidosis (pH corrected with sodium bicarbonate), and inhibitors of endothelial as well as inducible
NO synthase on acute or sustained HPV (180 min) and endothelial permeability.
Results: In hypercapnic acidosis, HPV was intensified in sustained hypoxia, in contrast to hypercapnia without
acidosis when HPV was amplified during both phases. L-N
G-Nitroarginine (L-NNA), a non-selective NO synthase
inhibitor, enhanced acute as well as sustained HPV under all conditions, however, the amplification of sustained
HPV induced by hypercapnia with or without acidosis compared to normocapnia disappeared. In contrast 1400 W,
a selective inhibitor of inducible NO synthase (iNOS), decreased HPV in normocapnia and hypercapnia without
acidosis at late time points of sustained HPV and selectively reversed the amplification of sustained HPV during
hypercapnia without acidosis. Hypoxic hypercapnia without acidosis increased capillary filtration coefficient (Kfc).
This increase disappeared after administration of 1400 W.
Conclusion: Hypercapnia with and without acidosis increased HPV during conditions of sustained hypoxia. The
increase of sustained HPV and endothelial permeability in hypoxic hypercapnia without acidosis was iNOS
dependent.
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Acute and chronic respiratory disorders show a high
incidence and a high mortality rate of 40-60% worldwide
[1-3]. Acute respiratory dysfunctions as occurring in
intensive care under conditions like the adult respiratory
distress syndrome, lung edema or pneumonia, as well as
acute exacerbations of chronic obstructive lung disease
or acute neuromuscular damage may induce local or
global alveolar hypoxia and hypercapnia. Moreover,
hypercapnia is a common condition in the therapeutic
approach of permissive hypercapnic ventilation for the
treatment of patients with acute lung injury [1]. More
than six decades ago it has been concluded by von Euler
and Liljestrand that alveolar hypoxia induces HPV for
ventilation-perfusion matching in the lung [4]. HPV is
the physiological response of precapillary vessels
exposed to acute (0-30 min), as well as sustained alveo-
lar hypoxia (> 30 min), in order to improve pulmonary
gas exchange under conditions of local hypoxia [5]. Sus-
tained HPV may result in the development of acute pul-
monary hypertension under conditions of general
alveolar hypoxia. However, it is still controversial how
hypercapnia or acidosis affects pulmonary vascular tone
and hypoxic vasconstriction. Whereas evidence exists
that metabolic acidosis increases pulmonary arterial
pressure (PAP), there are inconsistent findings as to
whether hypercapnic acidosis has any effect on pulmon-
ary arterial pressure [6-8]. Some reports have pointed
o u tt h a ti ni s o l a t e dl u n gp r e parations hypercapnia with
normal pH increases, whereas others suggested that it
does not change pulmonary vascular tone [9-12].
We recently showed, that hypercapnic acidosis amplified
the acute phase of HPV (lasting up to 10 minutes) and
improved ventilation-perfusion matching [13], but it is still
unknown, if this is true in pathological conditions of sus-
tained hypoxia lasting much more than minutes and at
least several hours. In this regard it is important to men-
tion that the acute phase and the sustained phase of HPV
are suggested to be regulated, at least in part, by different
mechanisms [13,14]. In addition, the sustained phase may
be clinically more relevant, as the conditions of repiratory
dysfunction, as detailed above, can lead to conditions of
prolonged hypoxia, lasting longer than several minutes
[15]. Besides a possible deterioration of ventilation-perfu-
sion matching, disturbance of pulmonary gas exchange
might be aggravated by development of pulmonary edema
during exposure to prolonged hypoxia with hypercapnia.
Nitric oxide (NO) is known as an important modula-
tor of HPV. However, its detailed role for the effects of
hypercapnia on HPV is unknown [16,17]. Both, a
decrease of NO production during hypercapnia [18-20],
as well as an increase in NO production [21-23] has
been shown. It was also suggested that the NO produc-
tion does not change or does not contribute to the
regulation of pulmonary vascular tone at above condi-
tions [12,24]. Particularly, 1) the general role of NO
synthases (NOS), 2) a differentiation between the role of
endothelial NOS (eNOS) and inducible NOS (iNOS), as
well as 3) effects of NO synthase inhibitors (L-NNA and
1400 W, respectively) on sustained HPV under hyper-
capnia have not been investigated yet.
A g a i n s tt h i sb a c k g r o u n d ,w e1 )c o m p a r e dt h ee f f e c t s
of hypercapnia with or without acidosis on HPV and
endothelial permeability under conditions of acute and
sustained hypoxia and 2) deciphered the potential thera-
peutic effects of NO inhibitors in such conditions. Our
investigations were performed in isolated, perfused and
ventilated rabbit lungs, a model that allows detailed
quantification of pulmonary hemodynamic and bio-
chemical events without interference with systemic reg-
ulatory mechanisms.
Methods
Lung isolation, perfusion, and ventilation
Animal experiments were approved by the local authori-
ties (Regierungspräsidium Giessen) in Germany. The
model of isolated perfused rabbit lungs has been
described previously [25]. Briefly, pathogen free male
rabbits (body weight 2.8-3.8 kg) were deeply anaesthe-
tized with an i.v. application of ketamine (30-50 mg/kg)
and xylazine (6-10 mg/kg) and treated with the anticoa-
gulant heparin (1000 U/kg body weight). The trachea
was cannulated and animals were ventilated with room
air (tidal volume 30 ml, frequency 30 strokes/min). The
lungs were perfused with Krebs-Henseleit solution (per-
fusate) through the pulmonary artery. After rinsing the
lungs with 1 liter of the perfusate for washout of the
blood, the perfusion circuit was closed for circulation
and the start of the experiments. Meanwhile, the flow
rate was slowly increased from 20 to 150 ml/min, and
concomitantly the left atrial pressure was set at 2
mmHg. A positive end expiratory pressure of 2 cm H2O
was chosen for prevention of regional alveolar collapse.
The isolated perfused lung was placed in a temperature
equilibrated housing chamber and freely suspended from a
force transducer (Hottinger Baldwin, Germany) for contin-
uous monitoring of organ weight. The whole system (per-
fusate, reservoirs, tubing, and housing chamber) was
heated to 38.5°C. Pressures in the pulmonary artery, left
atrium, and trachea were continuously registered. All
lungs included in the study 1) exhibited a homogeneous
white appearance with no signs of hemostasis, edema, or
atelectasis, 2) revealed a constant mean pulmonary artery
and peak ventilation pressures in the normal range, and 3)
were isogravimetric during the first 20 min of steady state
period. Because flow-rate of the perfusate was constant,
changes in pulmonary artery pressure are proportional to
pulmonary vascular resistance.
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Four different gas mixtures were employed for ventila-
tion of the lung during different experimental conditions
(Gas Mixing Chamber, KM 60-3/6MESO, Witt, Witten,
FRG, Germany): 1) normoxia plus normocapnia: 21.0%
O2,5 . 3 %C O 2 balanced with N2,2 )n o r m o x i ap l u s
hypercapnia: 21.0% O2, 11.0% CO2, balanced with N2,3 )
hypoxia plus normocapnia: 3.0% O2,5 . 3 %C O 2 balanced
with N2, 4) hypoxia plus hypercapnia: 3.0% O2, 11.0%
CO2 balanced with N2. The perfusate used for the study
contained 120.0 mM NaCl, 1.1 mM K2HPO4,1 . 3m M
MgCl2,4 . 3m MK C l ,2 . 4m MC a C l 2, 13.3 mM glucose,
50 g hydroxy-ethyl-amylopectin (MW: 200000). In non-
acidotic experiments pH was adjusted with NaHCO3
(sodium-bicarbonate 1 M 8.4% [Serag-Wiessner KG]) to
a physiological range of 7.35-7.40.
In all groups, PO2,P C O 2 and pH of the perfusate
were measured with a gas analyzer 10 min after starting
the experiment and then, 10 min after initiating experi-
mental conditions. Table 1 shows the values taken 10
min after initiating each experimental condition. The
values of PO2, PCO2 and pH remained stable during the
time course of each experiment.
Gravimetric determination of capillary filtration
coefficient
Capillary filtration coefficient (Kfc) was quantified to
assess changes in capillary permeability by a hydrostatic
challenge. It was determined gravimetrically from the
slope of the lung weight-gain curve induced by a step-
wise elevation of venous pressure by 5.5 mmHg for 8
minutes, as described previously [26].
Evaluation of exhaled NO
The technique of measurement of exhaled NO levels has
been described previously [17]. In brief, an aliquot of the
mixed expired gas was continuously forwarded to a che-
miluminescence NO analyzer (280 NOA; Sievers Instru-
ments, Boulder, CO) to measure exhaled NO
concentration.
Study protocol
Forty minutes after the establishment of normoxic nor-
mocapnic ventilation, the first hydrostatic challenge was
performed by elevating pulmonary venous outflow pres-
sure from 2.0 to 7.5 mmHg for 8 min. Fifteen minutes
later, a 10 min period of hypoxic ventilation was per-
formed to determine the response to alveolar hypoxic
normocapnia, in order to ensure comparable vasoreac-
tive potential of the pulmonary vasculature of the indivi-
dual lungs. Subsequently, hypoxic normocapnic
ventilation of the lung was changed to 15 min normoxic
normocapnic ventilation. Thereafter, each lung was ran-
domly ventilated for 180 min (0-30 min: acute phase,
30-180 min: sustained phase) with different gas mixtures
as described above (please refer to: experimental condi-
tions) followed by 10 min normoxic normocapnic venti-
lation (180-190 min: recovery phase). Thirty minutes
later, a second Kfc measurement was performed. In the
pharmocologically treated groups, L-NNA (200 μM) or
1400 W (2 μM) was added to the perfusate 10 min
prior to the onset of the first hydrostatic challenge.
Statistical Analysis
Data are given as mean ± SEM. Analysis of variance
(ANOVA) with the Student-Newman-Keuls (SNK) post
hoc test was used for comparison of more than two
groups. For comparison of the values during the time
course of one group, one way ANOVA for repeated
measurements with SNK post hoc analysis was used.
For the comparison of two groups a Student’st - t e s tw a s
applied. Significance was assumed for P < 0.05.
Results
Effect of hypercapnia with and without acidosis on HPV
in the presence and the absence of L-NNA and 1400 W
Mean normoxic normocapnic pulmonary artery pressure
(PAP) values prior to the onset of hypoxia were 10.0 ±
1.5 mmHg (n = 7). During hypoxic normocapnia, the
initial increase of PAP (ΔPAP) reached the maximum
value of 4.0 ± 0.5 mmHg at 6 min after induction of
Table 1 pH, PCO2,P O 2 and [HCO3
-] in the perfusate during the different experimental conditions
Parameters Normoxic
normocapnia
Normoxic
hypercapnic
acidosis
Normoxic
hypercapnia
w/o acidosis
Hypoxic
normocapnia
Hypoxic
hypercapnic
acidosis
Hypoxic
hypercapnia
w/o acidosis
PO2 (mmHg) 158 ± 2 162 ± 1 165 ± 0 51 ± 7 * 62 ± 1 * 64 ± 1 *
PCO2 (mmHg) 37 ± 0 71 ± 1 * 72 ± 0 * 37 ± 0 72 ± 0 * 72 ± 1 *
pH 7.38 ± 0.00 7.08 ± 0.00 * 7.38 ± 0.00 7.36 ± 0.00 7.09 ± 0.00 * 7.38 ± 0.00
[HCO3
-] (mmol/L) 21 ± 0 21 ± 0 42 ± 0 * 20 ± 0 21 ± 0 41 ± 0 *
Data are mean ± SEM for n = 5-8 experiments each, derived 10 min after initiating each experimental condition. No difference of the respective parameters
could be detected during the course of the experiment (data not shown). In hypercapnia with normal pH, pH was corrected to the given values by the addition
of sodium bicarbonate.
* indicates significant differences as compared to normoxia or normocapnia.
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Figure 1 Effects of hypercapnia with or without acidosis on changes in pulmonary arterial pressure (ΔPAP) during hypoxia, and
normoxia. A. Changes of PAP in hypoxic normocapnia (n = 7), hypoxic hypercapnic acidosis (n = 7), and hypoxic hypercapnia without acidosis
(n = 8) during 180 min of hypoxic ventilation, followed by 10 min ventilation with normoxic normocapnic gas (recovery). ΔPAP: change of PAP
referenced to the baseline value at time set at zero. B. Changes of PAP in normoxic normocapnia (n = 8), normoxic hypercapnic acidosis (n = 8)
and normoxic hypercapnia without acidosis (n = 7) during 190 min normoxic ventilation. ΔPAP: change of PAP referenced to the value at time
set at zero. All data are mean ± SEM. *, significant difference (P < 0.05) between hypoxic normocapnia and hypoxic hypercapnic acidosis. #,
significant difference (P < 0.05) between hypoxic normocapnia and hypoxic hypercapnia without acidosis. §, significant difference (P < 0.05)
between hypoxic hypercapnic acidosis and hypoxic hypercapnia without acidosis.
Ketabchi et al. Respiratory Research 2012, 13:7
http://respiratory-research.com/content/13/1/7
Page 4 of 16hypoxia ("acute phase”), was followed by a decline to a
ΔPAP of 1.6 ± 0.2 mmHg at minute 14, and then
remained stable up to minute 18. Subsequently, in the
sustained phase of HPV, ΔPAP was gradually elevated
reaching a maximum value of 4.0 ± 0.4 mmHg at 175
min ("sustained phase”, Figure 1A).
Mean normoxic normocapnic PAP values before the
onset of hypoxic hypercapnic acidosis were 10.1 ± 0.5
mmHg (n = 7). Ventilation with hypoxic hypercapnic
acidosis resulted in an enhancement of the sustained
phase of HPV compared to normocapnia, ΔPAP ranged
from 5.2 ± 0.5 mmHg at minute 150 to 5.7 ± 0.5
mmHg at minute 180, whereas the maximal strength of
HPV during the acute phase (ΔPAP 4.2 ± 0.5 mmHg at
minute 4) was unchanged, but showed a faster rise (3.5
± 0.6 mmHg during hypoxic hypercapnic acidosis vs. 1.8
± 0.4 mmHg during hypoxic normocapnia at minute 2)
(Figure 1A).
Mean normoxic normocapnic PAP values before the
onset of hypoxic hypercapnia without acidosis were 9.9
± 0.4 mmHg (n = 7). Correction of acidosis with sodium
bicarbonate in the hypoxic hypercapnia without acidosis,
resulted in increased HPV during the acute as well as
the sustained phase compared to hypoxic normocapnia.
The initial strong vasoconstrictive response (maximum
value of 5.6 ± 0.3 mmHg at 6 min of exposure) declined
t o2 . 7±0 . 2m m H ga t1 8m i n .T h e r ew a sn os i g n i f i c a n t
difference between the values of ΔPAP during the sus-
tained phase of the maneuvers in the hypoxic hypercap-
nic with or without acidosis groups (Figure 1A).
There were no significant changes in normoxic pres-
sure during the course of the experiments in normoxic
normocapnia or normoxic hypercapnia with or without
acidosis groups (Figure 1B).
Hypoxia led to a reduced lung weight during all three
conditions compared to normoxia. In hypoxia, the
decremental changes of lung weight during 5-15 min
were larger in the hypoxic hypercapnia without acidosis
group than the hypoxic normocapnic group, but no dif-
ference was detectable between hypoxic normocapnia
and hypoxic hypercapnic acidosis (Figure 2).
In the presence of L-NNA, no significant changes of
pulmonary artery pressure were detectable under nor-
moxic ventilation, although a tendency towards higher
values at later time points was evident (Figure 3A, B, C).
Treatment with 1400 W did neither change normoxic
normocapnic PAP nor PAP during normoxic hypercap-
nic acidosis compared to the untreated group (Figure
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Figure 2 Effects of hypercapnia with or without acidosis on changes in lung weight during hypoxia, and normoxia.L u n gw e i g h t
changes of the respective experiments of figure 1. All data are mean ± SEM. #, significant difference (P < 0.05) between hypoxic normocapnia
and hypoxic hypercapnia without acidosis. ‡, significant difference (P < 0.05) between hypoxic groups and normoxic normocapnia.
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Page 5 of 163D, E). However, during normoxic hypercapnia without
acidosis 1400 W induced a significant PAP decrease at
m i n4 - 6a n da ni n c r e a s ea tm i n5 5 - 6 5c o m p a r e dt o
lungs in the absence of 1400 W (Figure 3F).
I nt h ep r e s e n c eo fL - N N A ,t h ea c u t ea n ds u s t a i n e d
phase of HPV was increased in all groups (Figure 4A, B,
C). In contrast, 1400 W decreased the sustained phase
of HPV at late time points in normocapnia and hypoxic
hypercapnia without acidosis, but not in hypoxic hyper-
capnic acidosis compared to the respective controls in
the absence of 1400 W (Figure 4D, E, F).
For better visualization of the effect of hypercapnia on
HPV in the presence of L-NNA or 1400 W, ΔPAP
values of the normocapnic and hypercapnic groups from
F i g u r e3a n d4a r ed i s p l a y e di nF i g u r e5 A / Ba n d7 A / B
in a direct comparison. In the presence of L-NNA the
effects of hypercapnia on acute HPV were similar (Fig-
ure 5A) as in the absence of L-NNA (Figure 1A) but the
increase in sustained hypoxia was no longer significant,
compared to hypoxic normocapnia. Normoxic values
were not different between the groups in presence of L-
NNA (Figure 5B). Moreover, during L-NNA treatment
the lung weights showed no difference between hypoxic
groups (Figure 6). In presence of 1400 W, ΔPAP was
increased in sustained hypoxic hypercapnic acidosis at
150-182 min, but not in hypercapnia without acidosis
compared to hypoxic normocapnia. Acute HPV was still
increased (minutes 4-16) during hypoxic hypercapnia
without acidosis compared to hypoxic normocapnia,
similar to the effect in the absence of 1400 W (Figure
7A). Normoxic values were not different between the
groups in presence of 1400 W (Figure 7B). Moreover,
during 1400 W treatment the lung weights showed no
difference between hypoxic groups (Figure 8).
Effect of hypoxia, hypercapnia with and without acidosis
on NO production
In normoxic normocapnia, exhaled NO decreased gra-
dually reaching a minimum of 73 ± 2% of its baseline
value at 180 min of normoxic ventilation. In normoxic
hypercapnia with or without acidosis, exhaled NO
declined immediately to 79 ± 1% and 82 ± 1% of the
respective baseline valuesw i t h i n2m i no fn o r m o x i c
hypercapnic ventilation, respectively and remained sig-
nificantly lower than the normocapnic group up to 100
min of the experiment. In hypoxic normocapnia, the
exhaled NO rapidly decreased to 86 ± 3% of its baseline
value within 2 min of hypoxic ventilation, reached 66 ±
3% of its baseline value at 180 min of hypoxic ventila-
tion and was significantly different from normoxic nor-
mocapnia during the entire period of hypoxic
ventilation. In hypoxic hypercapnia with or without
acidosis exhaled NO dropped to 66 ± 1% and 71 ± 1%
of their baseline values, respectively, within 2 min of the
experiment. The exhaled NO values during the entire
period of the experiment in both hypoxic hypercapnia
groups were significantly lower than those of the nor-
moxic groups, as well as compared to hypoxic normo-
capnia (Figure 9).
Effect of hypoxia, hypercapnia with and without acidosis
on endothelial permeability in the presence and the
absence of L-NNA and 1400 W
T h ep o s t - h y p o x i aK fc value was significantly higher in
hypoxic hypercapnia withouta c i d o s i st h a ni nh y p o x i c
normocapnia and normoxic normocapnia, as well as
compared to its own pre-hypoxic value (Figure 10). This
effect was no longer detectable in the presence of 1400
W, but was still detectable in the presence of L-NNA
(Figure 10F). Post-hypoxic Kfc values of the other groups
were not different between each other and from their
own pre-hypoxic values (Figure 10A, B, C, D, E).
Discussion
Although it is known for decades that alveolar hypoxia
induces HPV, the effects of hypercapnia on pulmonary
vascular tone and capillary permeability under sustained
hypoxia, are still not fully elucidated. In addition, the
role of NO signaling under such conditions is not fully
understood yet. HPV is essential to optimize pulmonary
gas exchange during local acute and prolonged hypoxia.
As previously shown by our group, hypercapnia was
concluded to be beneficial for ventilation-perfusion
matching in conditions of repetitive acute hypoxic epi-
sodes, each lasting up to 10 minutes. Hypercapnic
acidosis improved arterial pO2,a n da u g m e n t e dH P V
without affecting endothelial permeability [13]. In exten-
sion of these investigations we now focused on the
effects of sustained hypoxic hypercapnia on HPV and
pulmonary endothelial permeability. Furthermore, we
addressed the role of endothelial and inducible NO
synthases in prolonged hypoxic hypercapnia.
Our data revealed that during sustained hypoxia both
hypercapnia with and hypercapnia without acidosis
increased HPV. However, only hypercapnia without
acidosis enhanced acute HPV in the first minutes of the
hypoxic ventilation, as shown for short term hypoxia in
our previous study [13]. This finding is reminiscent of
the effect of hypercapnia on repetitive episodes of short
term HPV, when hypercapnia without acidosis increased
acute HPV during the first repetitive hypoxic maneu-
vers, but hypercapnia with acidosis enhanced HPV only
i nt h el a t ee p i s o d e so fr e p e t i t i v eh y p o x i cm a n e u v e r s
[13]. It is also in line with findings that hypercapnic
acidosis caused a marked increase in pulmonary vascular
resistance during a time period of 60-80 min hypoxia,
but not at earlier time points [27]. However, with regard
to the effect of hypercapnia on HPV, there are
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Figure 3 Effects of L-N
G-Nitroarginine (L-NNA) and N-([3-(Aminomethyl) phenyl] methyl) ethanimidamide dihydrochloride (1400 W) on
pulmonary vascular tone during normoxic ventilation. Normoxic ΔPAP values in the absence of L-NNA and 1400 W are identical to those
depicted in Figure 1. A. L-NNA-treated normoxic normocapnia (n = 5), B. L-NNA-treated normoxic hypercapnic acidosis (n = 5), C. L-NNA-treated
normoxic hypercapnia without acidosis (n = 4), D. 1400 W-treated normoxic normocapnia (n = 6), E. 1400 W-treated normoxic hypercapnic
acidosis (n = 4), F. 1400 W-treated normoxic hypercapnia without acidosis (n = 6) compared to ΔPAP from lungs in the absence of L-NNA or
1400 W during 190 min of normoxic ventilation. ΔPAP: change of PAP referenced to the value at time set at zero. Data are mean ± SEM. *,
significant difference (P < 0.05) between treated and untreated groups.
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Figure 4 Effects of L-NNA and 1400 W on the strength of HPV. Hypoxic ΔPAP values in the absence of L-NNA and 1400 W are identical to
those depicted in Figure 1. A. L-NNA-treated hypoxic normocapnia group (n = 5), B. L-NNA-treated hypoxic hypercapnic acidosis (n = 6), C.L -
NNA-treated hypoxic hypercapnia without acidosis (n = 5), D. 1400 W-treated hypoxic normocapnia (n = 6), E. 1400 W-treated hypoxic
hypercapnic acidosis (n = 5), F. 1400 W-treated hypoxic hypercapnia without acidosis (n = 5) compared to HPV in the absence of L-NNA or 1400
W during 180 min hypoxic ventilation, followed by 10 min ventilation with normoxic normocapnic gas (recovery). ΔPAP: change of PAP
referenced to the value at time set at zero. Data are mean ± SEM. *, significant difference (P < 0.05) compared to untreated groups.
Ketabchi et al. Respiratory Research 2012, 13:7
http://respiratory-research.com/content/13/1/7
Page 8 of 16Time (min)
0
2
4
6
8
1
0
1
2
1
4
1
6
1
8
2
0
4
0
6
0
8
0
1
0
0
1
2
0
1
4
0
1
6
0
1
8
0 -1.0
-0.5
0.0
0.5
1.0
1.5
2.0
L-NNA + Normoxic normocapnia
L-NNA + Normoxic hypercapnic acidosis
L-NNA + Normoxic hypercapnia without acidosis
1
8
0
1
8
2
1
8
4
1
8
6
1
8
8
1
9
0
1
8
0
1
8
2
1
8
4
1
8
6
1
8
8
1
9
0
Time (min)
0
2
4
6
8
1
0
1
2
1
4
1
6
1
8
2
0
4
0
6
0
8
0
1
0
0
1
2
0
1
4
0
1
6
0
1
8
0
0
2
4
6
8
10
12
L-NNA + Hypoxic normocapnia
L-NNA + Hypoxic hypercapnic acidosis
L-NNA + Hypoxic hypercapnia without 
acidosis
Acute phase                  Sustained phase              Recovery  
A
B
ǻ
P
A
P
 
(
m
m
H
g
)
 
ǻ
P
A
P
 
(
m
m
H
g
)
 
ns 
§
Figure 5 Effects of L-NNA on the strength of HPV during normocapnia and hypercapnia. ΔPAP values in the presence of L-NNA are
identical to those depicted in Figure 3 A-C and Figure 4 A-C. A. Changes in ΔPAP (ΔPAP) during 180 min hypoxic ventilation, followed by 10
min ventilation with normoxic normocapnic gas. ΔPAP: change of PAP referenced to the baseline value at time set at zero. B. Changes in PAP
(ΔPAP) during 190 min of normoxic ventilation. ΔPAP: change of PAP referenced to the value at time set at zero. All data are mean ± SEM. §,
significant difference (P < 0.05) between hypoxic hypercapnic acidosis and hypoxic hypercapnia without acidosis.
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Page 9 of 16inconsistent findings, with studies differing from our
data showing inhibition [28,29] or decrease of HPV [8].
Since, there were no statistically significant alterations
in PAP during the entire period of exposure to nor-
moxic hypercapnia, the increased ΔPAP in the sustained
phase of the hypoxic hypercapnic groups denotes to the
potentiating effect of hypercapnia on the hypoxic
response of pulmonary vasculature. In previous studies
hypercapnia was reported to induce vasoconstriction in
isolated rabbit lungs and rat arteries [10,12,30], vasodila-
tion in isolated rat lungs and arteries [31,32] or to have
no effect on pulmonary vascular tone in isolated rat
arteries [9,11] in normoxia. There are, however, differ-
ences in experimental conditions and protocols that
might explain these conflicting results.
Examining the role of NO, our study suggests 1) that
NO counteracts the increase of PAP in both phases of
HPV, but has no effect on pulmonary vascular tone
under normoxic conditions, 2) that the increase of the
sustained phase of HPV during hypoxic hypercapnia
without acidosis, and partially during hypoxic normo-
capnia, is related to iNOS, whereas the increase in
hypoxic hypercapnia with acidosis is related to eNOS, as
during general NOS inhibition the significant increase of
sustained HPV caused by hypercapnia with and without
acidosis disappeared, whereas such an effect was only
true for the iNOS inhibitor during hypercapnia without
acidosis. This statement is, with regard to eNOS, how-
ever, only valid, if a potential role of nNOS can be
neglected as suggested by measurements in nNOS
knock-. out mice that showed no alteration of HPV and
endothelial dependent or endothelial independent vaso-
constriction in isolated lungs [33]. 3) Our data show
that iNOS activity, but not eNOS activity is responsible
for the increase in endothelial permeability occurring
only during hypoxia without acidosis, as only the iNOS
inhibitor, but not general NOS inhibition by L-NNA
prevented the increase in the capillary filtration
coefficient.
The first conclusion is based on the findings, that dur-
ing normoxia inhibition of NOS by L-NNA did not
change the level of vascular tone and inhibition of iNOS
showed only a decrease of ΔPAP during normoxic
hypercapnia without acidosis at the beginning and
increase of ΔPAP at ~60 min of the experiments. In
contrast, L-NNA increased PAP during all conditions in
hypoxia. As the iNOS inhibitor had not such an effect,
most probably eNOS is responsible for this amplification
of in acute and sustained HPV. In line with these find-
ings it has been shown that NO is not involved in
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Figure 7 Effects of 1400 W on the strength of HPV during normocapnia and hypercapnia. ΔPAP values in the presence of 1400 W are
identical to those depicted in Figure 3 D-F and Figure 4 D-F. A. Changes in PAP (ΔPAP) during 180 min hypoxic ventilation, followed by 10 min
ventilation with normoxic normocapnic gas. ΔPAP: change of PAP referenced to the value at time set at zero. B. Changes of PAP (ΔPAP) during
190 min of normoxic ventilation. ΔPAP: change of PAP referenced to the value at time set at zero. All data are mean ± SEM. *, significant
difference (P < 0.05) between hypoxic normocapnia and hypoxic hypercapnic acidosis. #, significant difference (P < 0.05) between hypoxic
normocapnia and hypoxic hypercapnia without acidosis. §, significant difference (P < 0.05) between hypoxic hypercapnic acidosis and hypoxic
hypercapnia without acidosis.
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Page 11 of 16regulation of normoxic pulmonary vascular tone, neither
during normocapnia [34,35] nor during hypercapnia
[8,12], although some interspecies variability may exist
[34,36]. Thus, NO is involved in the regulation of pul-
monary vascular responses to hypoxia as previously
shown [5,36].
The second conclusion is based on the findings of dif-
ferential amplification and inhibition of HPV, by general
NOS inhibition with L-NNA and specific iNOS inhibi-
tion with 1400 W, respectively. General NOS inhibition
increased acute and sustained HPV in all conditions and
eliminated the difference between hypoxic normocapnia
and hypoxic hypercapnia with and without acidosis in
sustained HPV. Specific iNOS inhibition only inhibited
t h ed i f f e r e n c eb e t w e e nh y p o x i cn o r m o c a p n i aa n d
hypoxic hypercapnia without acidosis in sustained HPV.
Thus, eNOS may be responsible for the amplification of
sustained HPV in hypercapnic acidosis, whereas iNOS
may be responsible for the amplification of sustained
HPV in hypercapnia without acidosis. Acute HPV, how-
ever, seems to be potentiated in hypercapnia without
acidosis by different mechanisms than NO release. The
fact that application of 1400 W did not alter ΔPAP at
e a r l yt i m ep o i n t si nh y p o x i ai sc o n s i s t e n tw i t har e p o r t
of Resta et al. showing that iNOS does not modulate
pulmonary vasoconstriction in response to a
thromboxane analogue [37]. However, in sustained
hypoxia 1400 W decreased ΔPAP in hypoxic normocap-
nia and hypoxic hypercapnia without acidosis, which
may be due to upregulation of iNOS in long term
hypoxia, as shown before [37]. Uncoupled iNOS activity
may lead to production of reactive oxygen and nitrogen
species (ROS/RNS), which are suggested to increase
HPV [38]. Hypercapnic acidosis may prevent such
effects as sustained HPV was not changed in hypoxic
hypercapnic acidosis. Along these lines decreased pro-
duction of ROS and RNS has been shown in hypercap-
nic hypoxia [39]. Although we can only speculate about
the effects of iNOS inhibition on ΔPAP in normoxic
hypercapnia without acidosis, the missing effect at late
time points supports the finding of a specific activation
of iNOS by hypercapnia without acidosis in hypoxia.
During hypoxia the biphasic increase of ΔPAP is par-
alleled by a concomitant reduction in exhaled NO, as
shown before for pure hypoxia by our laboratories [5].
The more pronounced decrease of NO during hypoxic
hypercapnia correlated to increased sustained HPV com-
pared to hypoxic normocapnia. However, elevated acute
HPV in hypoxic hypercapnia without acidosis compared
to hypercapnic acidosis did not correspond to a different
NO release, which emphasizes the importance of other
factors than NO transmitting the effects of hypercapnia
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Figure 8 Effects of 1400 W on lung weight during normocapnia and hypercapnia. Lung weight changes of the respective experiments of
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Page 12 of 16on acute HPV. In line with this explanation, inhibition
of NO production did not potentiate short term HPV
under hypercapnic acidosis [22,40].
Our third conclusion is based on the findings that
only hypercapnia without acidosis resulted in an
increased capillary filtration coefficient (Kfc) after sus-
tained hypoxia. This effect is in accordance with find-
ings that hypercapnic acidosis did not influence
pulmonary capillary permeability in repetitive short
term hypoxia [13,41,42] or even decreased edema for-
mation in acute lung injury, whereas buffering of hyper-
capnia with bicarbonate worsened lung injury [43]. This
effect may be related to the acidosis induced by hyper-
capnia, as metabolic acidosis is known to be protective
against ischemia-reperfusion induced lung injury in rat
lungs [44]. Hypercapnia, in contrast, has been reported
to exert damaging effects in the lung [21,23,45-48]. The
increase in Kfc during hypercapnia without acidosis
could be inhibited by 1400 W, but not by L-NNA in
our study, being in line with previous studies showing
that iNOS inhibition is protective against the cellular
damage during hypercapnic acidosis [49]. Additionally,
hypercapnia has been reported to induce injury in the
fetal rat alveolar epithelial cells through a NO depen-
dent pathway [21]. The increase in Kfc during hypercap-
nia without acidosis in repetitive episodes of short term
hypoxia, however, could also be inhibited by L-NNA
[13], which indicates that sustained hypoxia rather acti-
vates iNOS than eNOS. The protective effect of iNOS
inhibition on the Kfc increase in hypercapnia without
acidosis can, besides a direct effect of NO on endothelial
integrity also (at least in part) be related to the
decreased pulmonary artery pressure caused by 1400 W
application.
Conclusion
Our study showed that hypercapnia with and without
acidosis has different effects on the acute and sustained
phase of HPV. Hypercapnic acidosis may have beneficial
effects on ventilation-perfusion matching during pro-
longed hypoxia by increasing HPV and preserving pul-
monary capillary integrity. However, it must also be
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Page 13 of 16taken into account that prolonged hypoxic hypercapnia
can facilitate right heart failure. As the hypoxia-induced
increase in pulmonary vascular resistance is rather low
[50,51] this may be mainly important in predispositioned
patients, if our findings are transferable to the human
situation. Whereas general NOS inhibition increased
acute and sustained HPV during normocapnia and
hypercapnia with and without acidosis, iNOS inhibition
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Page 14 of 16decreased sustained HPV in normocapnia and hypercap-
nia without acidosis. In addition the increase of endothe-
lial permeability in hypercapnia without acidosis can be
attributed to increased iNOS activity.
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